Table 3.
Laboratory indices throughout treatment course, by patient group
| Treatment group (n=20) | Comparator group (n=24) | p value | |
|---|---|---|---|
| Haemoglobin, minimum (g/L) | 7·15 (2·13) | 8·13 (1·78) | 0·101 |
| Haemoglobin change, maximum (g/L) | −4·32 (2·47) | −2·14 (1·90) | 0·002 |
| Peripheral white cell count, minimum (×109/L) | 5·04 (3·36) | 5·71 (2·08) | 0·421 |
| Absolute neutrophil count, minimum (×109/L) | 2·90 (1·87) | 4·42 (1·89) | 0·017 |
| Minimum lymphocyte count, minimum (×109/L) | 1·07 (2·55) | 0·53 (0·29) | 0·310 |
| Platelet count, minimum (×109/L) | 117·80 (62·73) | 113·92 (59·28) | 0·834 |
| Alanine transaminase, maximum (IU/L) | 139·35 (189·63) | 152·75 (269·03) | 0·852 |
| Aspartate transaminase, maximum (IU/L) | 1195·84 (2890·29) | 859·87 (1650·26) | 0·639 |
| Serum bilirubin, maximum (μmol/L) | 70·95 (134·21) | 59·50 (98·33) | 0·746 |
| Alkaline phosphatase, maximum (IU/L) | 255·65 (243·97) | 398·17 (430·52) | 0·196 |
| Serum creatinine, maximum (μmol/L) | 310·70 (161·04) | 329·17 (223·75) | 0·759 |
| Serum albumin, minimum (g/L) | 21·05 (2·81) | 21·04 (4·36) | 0·995 |
Data are mean (SD).